nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—focal segmental glomerulosclerosis	0.914	1	CbGaD
Gadobenate Dimeglumine—Tonsillitis—Cyclosporine—focal segmental glomerulosclerosis	0.00542	0.0631	CcSEcCtD
Gadobenate Dimeglumine—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.0325	CcSEcCtD
Gadobenate Dimeglumine—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.0295	CcSEcCtD
Gadobenate Dimeglumine—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.0288	CcSEcCtD
Gadobenate Dimeglumine—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.0281	CcSEcCtD
Gadobenate Dimeglumine—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.0271	CcSEcCtD
Gadobenate Dimeglumine—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.0229	CcSEcCtD
Gadobenate Dimeglumine—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.0221	CcSEcCtD
Gadobenate Dimeglumine—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.0219	CcSEcCtD
Gadobenate Dimeglumine—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.0203	CcSEcCtD
Gadobenate Dimeglumine—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.0203	CcSEcCtD
Gadobenate Dimeglumine—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.0175	CcSEcCtD
Gadobenate Dimeglumine—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0167	CcSEcCtD
Gadobenate Dimeglumine—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0167	CcSEcCtD
Gadobenate Dimeglumine—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.0157	CcSEcCtD
Gadobenate Dimeglumine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0154	CcSEcCtD
Gadobenate Dimeglumine—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.015	CcSEcCtD
Gadobenate Dimeglumine—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.0146	CcSEcCtD
Gadobenate Dimeglumine—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0139	CcSEcCtD
Gadobenate Dimeglumine—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0132	CcSEcCtD
Gadobenate Dimeglumine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0129	CcSEcCtD
Gadobenate Dimeglumine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.0128	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0121	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0119	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0119	CcSEcCtD
Gadobenate Dimeglumine—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0119	CcSEcCtD
Gadobenate Dimeglumine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000978	0.0114	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000931	0.0108	CcSEcCtD
Gadobenate Dimeglumine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000845	0.00983	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000826	0.00961	CcSEcCtD
Gadobenate Dimeglumine—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000823	0.00958	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000793	0.00923	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000775	0.00902	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000766	0.00891	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000766	0.00891	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000753	0.00876	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000744	0.00866	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000744	0.00866	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00073	0.0085	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000689	0.00802	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000684	0.00796	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000679	0.0079	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000676	0.00786	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000674	0.00784	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000663	0.00771	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000641	0.00746	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000638	0.00743	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000624	0.00726	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00062	0.00721	CcSEcCtD
Gadobenate Dimeglumine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000617	0.00718	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000614	0.00715	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000602	0.00701	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000598	0.00696	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000586	0.00682	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000575	0.0067	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000561	0.00653	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000555	0.00646	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000553	0.00644	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000547	0.00636	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00054	0.00628	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000536	0.00623	CcSEcCtD
Gadobenate Dimeglumine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000522	0.00608	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000517	0.00601	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00593	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00593	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00593	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000508	0.00591	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000506	0.00589	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.00586	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000498	0.0058	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000493	0.00573	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000488	0.00568	CcSEcCtD
Gadobenate Dimeglumine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000485	0.00565	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000479	0.00557	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000474	0.00552	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000472	0.00549	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000445	0.00518	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000439	0.0051	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.00507	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000434	0.00505	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00043	0.005	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000422	0.00491	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.0049	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000418	0.00486	CcSEcCtD
Gadobenate Dimeglumine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000418	0.00486	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000403	0.00468	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000399	0.00465	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000388	0.00452	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000386	0.00449	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000386	0.00449	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00036	0.00419	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00035	0.00408	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000346	0.00402	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.00389	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000323	0.00376	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000311	0.00361	CcSEcCtD
Gadobenate Dimeglumine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000308	0.00358	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000308	0.00358	CcSEcCtD
Gadobenate Dimeglumine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000306	0.00356	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.00338	CcSEcCtD
